Advisornet Financial’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Advisornet Financial’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1	Closed	-$102	–	2446
2023 Q2	$102	Buy	+1	New	+$95	﹤0.01%	2269

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Advisornet Financial's RETA Position: Q3 2023 in Review

Advisornet Financial sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 1 share — an estimated $102 sold.

Advisornet Financial first reported a position in RETA in Q2 2023 and held it in 1 quarter. The position peaked at $102 in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Advisornet Financial reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Advisornet Financial sold 1 Reata Pharmaceuticals, Inc. Class A Common Stock share in Q3 2023, an estimated $102.
Advisornet Financial first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
Advisornet Financial's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $102 in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Advisornet Financial's 13F filing for Q3 2023, filed 12 Oct 2023.